Table 3 Association of the UroSEEK gene panel with outcome

From: Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma

 

Recurrence

P-value

Progression

p-value

 

Yes

No

 

Yes

No

 

N = 132

N = 171

N = 21

N = 282

Mutation in UroSEEK genes

124/132

163/171

0.784

17/21

270/282

0.016

(94%)

(95%)

(81%)

(96%)

Mutation in TERTSeqS

101/132

115/171

0.101

12/21

204/282

0.217

(77%)

(67%)

(57%)

(72%)

Mutation in UroSeqS

87/132

120/171

0.505

12/21

195/282

0.369

(66%)

(70%)

(57%)

(69%)

  1. Assay categories (UroSEEK and its components) and significant p-value are listed in bold